Orthobiologics Market Size to touch USD 7,725.6 Million by 2027
The report analyzes and forecasts the Orthobiologics Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Orthobiologics Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Orthobiologics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Orthobiologics Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2397
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The players profiled in the report include Arthrex, Inc. (Arthrex), Exactec Inc., Globus Medical, Inc., Integra LifeSciences Holdings Corporation, Johnson and Johnson (J&J), Medline Industries, Inc., NuVasive Inc., Stryker Corporation, Wright Medical Group, Inc., and Zimmer Biomet Holdings, Inc. The major orthobiologics players were involved in strategic developments for escalating the profit share in regional as well as global market. The major investments were announced for the technological advancements associated with the changing consumer demand for orthobiologics
The major market segments of Orthobiologics Market are as below:
Market By Product
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
Market By Application
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications
Market By End User
Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
Research and Academic Institutes
Dental Clinics and Facilities
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Orthobiologics
1.1. Definition and Scope
1.1.1. Definition of Orthobiologics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Orthobiologics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Orthobiologics Market By Product
1.2.3. Orthobiologics Market By Application
1.2.4. Orthobiologics Market By End User
1.2.5. Orthobiologics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Orthobiologics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Orthobiologics Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Orthobiologics Market By Product
4.1. Introduction
4.2. Orthobiologics Revenue By Product
4.2.1. Orthobiologics Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Demineralized Bone Matrix (DBM)
4.2.2.1. Demineralized Bone Matrix (DBM) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Allograft
4.2.3.1. Allograft Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Bone Morphogenetic Protein (BMP)
4.2.4.1. Bone Morphogenetic Protein (BMP) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Viscosupplementation Products
4.2.5.1. Viscosupplementation Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Synthetic Bone Substitutes
4.2.6.1. Synthetic Bone Substitutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Orthobiologics Market Revenue By Application
5.1. Introduction
5.2. Orthobiologics Revenue (US$ Mn) By Application
5.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
5.2.2. Osteoarthritis and Degenerative Arthritis
5.2.2.1. Osteoarthritis and Degenerative Arthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Spinal Fusion
5.2.3.1. Spinal Fusion Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Fracture Recovery
5.2.4.1. Fracture Recovery Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Soft Tissue Injuries
5.2.5.1. Soft Tissue Injuries Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Maxillofacial and Dental Applications
5.2.6.1. Maxillofacial and Dental Applications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Orthobiologics Market By End User
6.1. Introduction
6.2. Orthobiologics Revenue (US$ Mn) By End User
6.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
6.2.2. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
6.2.2.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Research and Academic Institutes
6.2.3.1. Research and Academic Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Dental Clinics and Facilities
6.2.4.1. Dental Clinics and Facilities Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Orthobiologics Market By Country
7.1. North America Orthobiologics Overview
7.2. U.S.
7.2.1. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Orthobiologics Market By Country
8.1. Europe Orthobiologics Market Overview
8.2. U.K.
8.2.1. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Orthobiologics Market By Country
9.1. Asia Pacific Orthobiologics Market Overview
9.2. China
9.2.1. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.2.2. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.2.3. China Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.3. Japan
9.3.1. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.3.2. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.3.3. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.4. India
9.4.1. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.4.2. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.4.3. India Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.5. Australia
9.5.1. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.5.2. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.5.3. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.6. South Korea
9.6.1. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.6.2. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.6.3. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
9.7.2. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.7.3. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Orthobiologics Market By Country
10.1. Latin America Orthobiologics Market Overview
10.2. Brazil
10.2.1. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.2.2. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.2.3. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.3. Mexico
10.3.1. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.3.2. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.3.3. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.4.2. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
CHAPTER 11. Middle East & Africa Orthobiologics Market By Country
11.1. Middle East & Africa Orthobiologics Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.2.2. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.2.3. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.3. UAE
11.3.1. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.3.2. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.3.3. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.4.2. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.4.3. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
CHAPTER 12. Player Analysis Of Orthobiologics
12.1. Orthobiologics Market Company Share Analysis
12.2. Mergers And Acquisition In Global Orthobiologics Market
CHAPTER 13. Company Profile
13.1. Arthrex, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Arthrex, Inc. 2019 Orthobiologics Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Manufacturing Plant Footprint Analysis
13.2. Exactec Inc.
13.3. Globus Medical, Inc.
13.4. Integra LifeSciences Holdings Corporation
13.5. Johnson and Johnson
13.6. Medline Industries, Inc.
13.7. NuVasive Inc.
13.8. Stryker Corporation
13.9. Wright Medical Group, Inc.
13.10. Zimmer Biomet Holdings, Inc.
13.11. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2397
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
